1. KT-Biologics I (KTB1): A dynamic simulation model for continuous biologics manufacturing.
- Author
-
Boskabadi, Mohammad Reza, Ramin, Pedram, Kager, Julian, Sin, Gürkan, and Mansouri, Seyed Soheil
- Subjects
- *
DYNAMIC simulation , *DYNAMIC models , *SIMULATION methods & models , *DRUG factories , *BIOLOGICALS , *GREEN business - Abstract
• A plant-wide model is presented for continuous biomanufacturing benchmarking. • The model includes a tailored control strategy for dynamic simulation performance. • Realistic sensors and actuators consider measurement's noise and lag time. • Case study framework and examples are provided for user guidance. The pharmaceutical industry's shift towards biological therapeutics has led to a transition from conventional batch production to continuous manufacturing. This change highlights the crucial need for effective process monitoring and control strategies to ensure consistent product quality and stability. Open-source benchmark simulation models have become essential tools for refining these processes, offering a platform for testing research hypotheses. This study uses the production of Lovastatin as a case study for continuous biopharmaceutical production. A comprehensive dynamic model covering upstream and downstream components provides an integrated perspective of the production process. The study introduces a basic control system emphasizing realistic sensor and actuator integration to enhance simulation accuracy. It assesses the benchmark through open-loop and closed-loop simulations, offering an in-depth analysis of the KTB1 model's dynamic response and functionality. KTB1 represents a model-driven decision support tool that enables the evaluation of monitoring strategies, process design, process optimization, and control for biomanufacturing. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF